Xcellerant Ventures — 2023 Investments
1 investments dated 2023 · listed companies and verified rows first · show all
Lenoss Medicallenoss.cominSeries A · Dec 2023 · $4M
Lenoss develops products aimed at advancing a physiological treatment pathway, supported by a team of industry professionals and clinical advisors.
BiotechHealthtechMedical DevicesProvidence, US
Dom Messerli, MBAinDominique Messerli(Executive Officer, Director)
Co-investorsAZ Venture Capital Inc.Beacon AngelsSlater Technology FundWalnut Venture Associates
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.